#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16542	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2290	718.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	953	C,A	873,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28932	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3565	809.7	0	.	n	.	0	A20C	SNP	20	20	A	308	308	C	530	C,A	501,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28932	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3565	809.7	0	.	n	.	0	T695C	SNP	695	695	T	983	983	C	900	C	832	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28932	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3565	809.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1926	1926	G	995	G	928	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28932	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3565	809.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2259	2259	C	949	C,T	869,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28932	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3565	809.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2333	2333	A	942	A	872	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28932	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3565	809.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2885	2885	C	910	C	854	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	16	blaTEM	861	218	100.0	blaTEM.l15.c4.ctg.1	218	2.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2018	folP	855	855	100.0	folP.l15.c4.ctg.1	1491	134.6	1	SNP	p	R229S	1	.	.	685	687	AGC	967	969	AGC	209;205;206	A;G;C	191;191;191	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5436	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3421	158.6	1	SNP	p	S91F	1	.	.	271	273	TTC	644	646	TTC	186;188;192	T;T,C;C	167;169,1;173	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5436	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3421	158.6	1	SNP	p	D95G	1	.	.	283	285	GGC	656	658	GGC	185;186;189	G;G;C	173;170;173	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5436	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3421	158.6	1	SNP	p	G95N	0	.	.	283	285	GGC	656	658	GGC	185;186;189	G;G;C	173;170;173	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1682	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1406	119.3	1	SNP	p	G45D	0	.	.	133	135	GGC	459	461	GGC	238;233;232	G;G;C	218;214;213	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	820	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c4.ctg.1	856	95.0	0	.	n	.	0	G98A	SNP	98	98	G	360	360	A	179	A	171	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	820	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c4.ctg.1	856	95.0	0	.	n	.	0	A197.	DEL	197	197	A	458	458	A	225	A	203	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3025	181.9	1	SNP	p	D86N	0	.	.	256	258	GAC	603	605	GAC	245;241;244	G;A;C	228;220;229	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3025	181.9	1	SNP	p	S87R	1	.	.	259	261	CGT	606	608	CGT	248;250;249	C,A;G;T	232,1;235;227	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3025	181.9	1	SNP	p	R87I	0	.	.	259	261	CGT	606	608	CGT	248;250;249	C,A;G;T	232,1;235;227	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3025	181.9	1	SNP	p	R87W	0	.	.	259	261	CGT	606	608	CGT	248;250;249	C,A;G;T	232,1;235;227	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5516	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3025	181.9	1	SNP	p	S88P	0	.	.	262	264	TCC	609	611	TCC	249;252;252	T;C;C	230;236;238	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4532	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2546	177.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1516	1518	GGC	221;221;219	G;G;C	202;203;200	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1208	1210	GCA	243;242;242	G;C;A	225;222;223	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1211	1213	ATC	240;242;243	A;T;C	220;220;223	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1223	1225	GTG	247;245;241	G;T;G	230;225;224	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1223	1225	GTG	247;245;241	G;T;G	230;225;224	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1727	1729	ACC	233;234;236	A;C;C	205;212;212	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1781	1783	GCG	221;220;221	G,A;C;G	192,1;179;187	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1781	1783	GCG	221;220;221	G,A;C;G	192,1;179;187	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1904	1906	AGC	203;200;199	A;G;C	183;181;179	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1913	1915	GGC	196;194;194	G,A;G;C	179,1;179;176	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2419	185.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1931	1933	CCG	169;174;176	C,G;C;G	120,8;131;133	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6020	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3159	190.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1674	1676	CCG	203;204;201	C;C,T;G	179;185,1;179	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2426	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1665	144.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	505	505	C	158	C	148	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	395	397	GAA	262;262;263	G;A;A	253;252;254	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	0	.	p	.	0	K41D	NONSYN	121	123	AAA	404	406	GAC	263;266;271	G;A;C	251;254;260	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	0	.	p	.	0	K120N	NONSYN	358	360	AAG	641	643	AAT	251;248;250	A,G;A,G;T	235,1;233,1;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	806	808	TCA	245;244;247	T;C;A	226;226;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	935	937	GTC	258;255;257	G;T;C	235;237;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1007	1009	GTT	238;237;236	G;T;T	214;212;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	1	SNP	p	A121D	1	.	.	361	363	GAC	644	646	GAC	247;249;249	G;A,C;C	232;233,1;237	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3152	porB1b	1047	1047	98.76	porB1b.l15.c17.ctg.1	1456	214.6	1	SNP	p	D121N	0	.	.	361	363	GAC	644	646	GAC	247;249;249	G;A,C;C	232;233,1;237	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11598	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4729	244.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1238	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1099	112.1	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	263;260;262	A;T;G	245;242;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
